Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$144.95 - $152.29 $3.37 Million - $3.55 Million
-23,278 Reduced 43.11%
30,716 $4.64 Million
Q2 2022

Aug 16, 2022

BUY
$83.14 - $145.99 $3.52 Million - $6.18 Million
42,354 Added 363.87%
53,994 $7.87 Million
Q1 2022

May 17, 2022

SELL
$110.08 - $142.92 $54,709 - $71,031
-497 Reduced 4.09%
11,640 $1.38 Million
Q4 2021

Feb 15, 2022

BUY
$99.73 - $148.48 $444,696 - $662,072
4,459 Added 58.08%
12,137 $1.67 Million
Q3 2021

Nov 16, 2021

SELL
$98.85 - $138.91 $7.8 Million - $11 Million
-78,882 Reduced 91.13%
7,678 $1.07 Million
Q2 2021

Aug 16, 2021

BUY
$65.78 - $105.02 $4.84 Million - $7.72 Million
73,505 Added 563.04%
86,560 $8.4 Million
Q1 2021

May 18, 2021

SELL
$64.07 - $91.75 $1.34 Million - $1.92 Million
-20,956 Reduced 61.62%
13,055 $893,000
Q4 2020

Feb 17, 2021

BUY
$65.07 - $98.24 $939,545 - $1.42 Million
14,439 Added 73.77%
34,011 $2.92 Million
Q3 2020

Nov 17, 2020

BUY
$59.04 - $77.95 $902,839 - $1.19 Million
15,292 Added 357.29%
19,572 $1.27 Million
Q2 2020

Aug 17, 2020

SELL
$29.01 - $74.23 $1.05 Million - $2.7 Million
-36,329 Reduced 89.46%
4,280 $313,000
Q1 2020

May 15, 2020

BUY
$27.51 - $57.29 $787,803 - $1.64 Million
28,637 Added 239.2%
40,609 $1.38 Million
Q4 2019

Feb 14, 2020

SELL
$40.86 - $57.65 $112,855 - $159,229
-2,762 Reduced 18.75%
11,972 $652,000
Q3 2019

Nov 14, 2019

SELL
$37.38 - $49.47 $294,180 - $389,328
-7,870 Reduced 34.82%
14,734 $615,000
Q2 2019

Aug 15, 2019

BUY
$39.79 - $67.01 $899,413 - $1.51 Million
22,604 New
22,604 $990,000
Q4 2018

Feb 15, 2019

SELL
$29.75 - $42.9 $422,122 - $608,708
-14,189 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$32.79 - $43.0 $88,369 - $115,885
-2,695 Reduced 15.96%
14,189 $533,000
Q2 2018

Aug 15, 2018

BUY
$23.62 - $42.29 $103,101 - $184,595
4,365 Added 34.87%
16,884 $667,000
Q1 2018

May 15, 2018

BUY
$22.49 - $34.56 $281,552 - $432,656
12,519 New
12,519 $322,000

Others Institutions Holding BHVN

About Biohaven Pharmaceutical Holding Co Ltd.


  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.18B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.